JCI vs TECH · P/E 44, rev $23.60B vs P/E 65, rev $1.22B
Johnson Controls International PLC (JCI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the JCI and TECH stock pages for the full models.
Not investment advice.